Zacks Investment Research. (See AT&T stock analysis on TipRanks) To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. These patches will reduce risk of BD … IVD assays, research use only (RUO) assays and user-defined protocols (UDP) cannot be combined in the same rack. The retirement crisis is both not as bad as it’s made out to seem—and also worse. YUPELRI underlies the lion’s share of Theravance’s revenue, which in Q3 reach $18.3 million. 25/09/2020 by sending BD MAX™ systems to develop tests for coronavirus5 BD announces product donations valued at $300,000 to Wuhan Red Cross and $50,000 to Project Hope5 The WHO announces official name for the disease caused by the novel coronavirus: COVID-192 CerTest Biotec and BD announce COVID-19 diagnostic test for BD MAX™ System with CE mark6 (To watch Louthan’s track record, click here) What does the rest of the Street think? Watching the markets with an eye to the main chance, Raymond James strategist Tavis McCourt sees both risk and opportunity in current market conditions. FRANKLIN LAKES, N.J., Nov. 23, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced new reporting capabilities for COVID-19 data, enabling scheduled reports to be generated from BD Synapsys™ Informatics (version 3.84). It is very important to do your own analysis before making any investment. It has not been authorized for use to detect any other viruses or pathogens. Tech stocks could come under pressure as President-elect Joe Biden's stimulus plan works its way through the U.S. economy. This is typical of utility companies in North America. For more information on BD, please visit bd.com. The BD MAX System is designed to help address today’s challenges, while preparing your laboratory for tomorrow’s possibilities. This was up 47% year-over-year, and was driven by a 124% increase in YUPELRI sales. Q3 earnings, at 48 cents per share, were just under the forecast, but were up 4% year-over-year and 2% sequentially. Given the alarming situation, medical technology giants have committed to take swift action for quick detection of the virus. Like many biopharmas, Theravance has high overhead and its approved drugs are at the start of their profitable lives. AT&T has kept its dividend strong for the past 12 years. Here's a list featuring GRWG stock, Square, Daqo and four other stocks expecting up to 156% growth. These Buy-rated tickers bring a dividend yield of 7%, a strong attraction for investors interested in using the current good times to set up a defensive firewall should the risks materialize. Tech billionaires have a lot of money and power. BD Synapsys™ Informatics solution provides secure connectivity, integrated workflows, and on-demand actionable insights for laboratories and facilities with Clinical Laboratory Improvement Amendments (CLIA) waivers. Each of these drugs leverages novel delivery of unique compounds against proven mechanisms-of-action and could offer superior safety and/or treatment effect, from their wider therapeutic windows,” Porges noted. ZARAGOZA, Spain and FRANKLIN LAKES, N.J., March 10, 2020 /PRNewswire/ -- CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 Real Time PCR Detection Kit adapted for the BD MAX ™ System has been CE marked to the IVD Directive (98/79/CE). Meanwhile, LabCorp LH announced the availability of LabCorp 2019 Novel Coronavirus test, effective Mar 5. About the BD Veritor™ System for Rapid Detection of SARS-CoV-2 Assay The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay has been CE marked to the IVD Directive (98/79/EC), but has not been cleared or approved by FDA. Contacts: Mela Sera, APR                                                      BD Public Relations                                                443-824-8012                                                      [email protected], Kristen M. Stewart, CFABD Strategy & Investor Relations201-847-5378[email protected], SOURCE BD (Becton, Dickinson and Company), Cision Distribution 888-776-0942 This paradoxical situation exists because of how we try to assess the state of retirement finance. BD Synapsys Informatics was among the first life science diagnostics informatics platforms to receive the Underwriters Laboratory Cybersecurity Assurance Program certification, an independent third-party evaluation that uses standardized, testable criteria for assessing software vulnerabilities and weaknesses. Theravance Biopharma (TBPH) We will start with Theravance, a biopharmaceutical company that focuses on developing organ-specific medications. The assay is based on the same viral RNA targeting sequences and real-time PCR detection method as the test developed by the U.S. Centers for Disease Control and Prevention ( CDC ). Marijuana stocks surged as a Democratic Senate adds to cannabis legalization momentum. Most financial markets will be closed for the celebration of the civil rights leader's life, the first one since protests over the killing of George Floyd touched off massive protests across the nation. Enterprise Products Partners (EPD) We’ll start in the energy sector, a business segment long known for both high cash flows and high dividends. Buy), and his $32 price target implies room for 10% growth from current levels. Another risk McCourt sees, beyond those two, would be a sharp rise in inflation. Becton, Dickinson and Company (BDX) : Free Stock Analysis Report, Stryker Corporation (SYK) : Free Stock Analysis Report, QIAGEN N.V. (QGEN) : Free Stock Analysis Report, Laboratory Corporation of America Holdings (LH) : Free Stock Analysis Report. “…product/service inflation is only really a possibility AFTER re-openings, so the market feels a bit bullet proof in the very near term, and thus the continued rally, with Dems winning the GA races just adding fuel to the stimulus fire,” McCourt noted. Coronavirus Live Streaming: Breaking news, world Map and live counter on total cases and recovered cases.I started this live stream on Jan 26th. By 2020, it's predicted to blast through the roof to $77.6 billion. (To watch Porges’ track record, click here) Overall, there are 5 reviews on file, and all are to Buy, making the Strong Buy consensus unanimous. At $1.80 annualized, the payment yields 7.9%. “Theravance’s respiratory medicines are its key near-term valuation drivers… We still forecast ~$2.4B in WW Triple sales at peak (2027E). COVID-19 Situation / COVID-19 claims 16 more, infects 813 in Bangladesh. One analyst, however, thinks this lower stock price gives investors an attractive entry point today. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. Raymond James analyst Frank Louthan sees AT&T as a classic defensive value stock, and describes T’s current state as one with the bad news ‘baked in.’ “[We] believe there is more that can go right during the next 12 months than can get worse for AT&T. BD Synapsys™ Informatics is an optional integrated informatics solution available to customers using the BD Veritor™ Plus System, a portable instrument delivering SARS-CoV-2 antigen test results in approximately 15 minutes, and the BD MAX™ System, a molecular diagnostic platform returning results in two to three hours. What are the fastest-growing stocks to watch in 2021? The test has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. The research programs range from Phase 1 to Phase 3 trials. For investors’ notice, CerTest Biotec is a Spanish developer and manufacturer of in-vitro diagnostic medical devices. This empowers customers to focus on what matters most: Caring for their patients.". We see EPD as arguably best positioned to withstand the volatile landscape… With EPD's footprint, demand gains, project growth, and contracted ramps should more than offset supply headwinds and lower y/y marketing results…" It’s not often that the analysts all agree on a stock, so when it does happen, take note. from 8 AM - 9 PM ET, HVAC (Heating, Ventilation and Air-Conditioning), Machine Tools, Metalworking and Metallurgy, Aboriginal, First Nations & Native American. That’s not all. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. "The solution's new encrypted reporting capabilities reduce the burden associated with manual reporting. That’s what the pros on Wall Street are here for. Whether markets move up or down, every investor loves a bargain. To this end, Porges rates TBPH an Outperform (i.e. The solution also offers configured reporting capabilities, which allow customers in the U.S. to generate reports in accordance with the U.S. Coronavirus Aid, Relief, and Economic Security (CARES) Act. ** BD FocalPoint Slide Profiler Workstation is currently undergoing patch validation for CVE-201-20685 † BD Veritor™ Connect NUC, BD MAX and BD Kiestra™ are currently undergoing patch validation for CVE-201-20685 and CVE-2019-6109. "For COVID-19 testing facilities – including labs, hospitals and nursing homes – the BD Synapsys™ Informatics solution's new reporting capabilities, supported by secure connectivity, simplifies the process of reporting test results to public health authorities.". The BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 Assay is not authorized for use by consumers or for at-home use. Boeing Co. got a bump in orders and deliveries of new planes in December, but it wasn’t enough to salvage a poor year for the big aircraft maker. Not only has the company felt confident to pay income to shareholders, it has also felt confident to invest heavily in renewable energy resources. Looking at the consensus breakdown, opinions from other analysts are more spread out. The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. BioGX developed the assay for the BD MAX™ System in their Sample-Ready™ ready-to-use format to detect the presence of the SARS-CoV-2 virus, the cause of COVID-19. Tùy chọn thời gian học trực tuyến mọi lúc, mọi nơi từ 8h đến 24h mỗi ngày với 100% giáo viên bản ngữ Âu - Úc - Mỹ trên mọi thiết bị di động. Additional configured reports can be developed, as needed. Covid-19, Featured. The stock’s $24.63 average price target suggests an upside of 9% from the current share price of $22.65. Throw in the fact that shares are heavily shorted, and we believe this is a recipe for upside. The House Democrats have passed articles of impeachment against President Trump, despite the imminent natural closure of his term of office, and that passage reduces the chances of political reconciliation in a heavily polarized environment. Revenues turned around, growing 27% sequentially to reach $6.9 billion in Q3. The United States is currently devastated by the coronavirus outbreak as the number of confirmed cases has already surpassed 1,000, with 31 reported deaths. President-elect Joe Biden’s $1.9 trillion “rescue plan” released on Thursday calls for three key tax improvements for 2021 that would help Americans across the income spectrum. Theravance owns royalty rights on Trelegy, with income estimated at 5.5% to 8.5% of total sales. A successful vaccination program will speed up the economic recovery, allowing states to loosen lockdown regulations – and get people back to work. Overall, Wall Street sees a clear path forward for NiSource – a fact clear from the unanimous Strong Buy consensus rating, based on 3 recent Buy-side reviews. These expenditures will fund ‘green’ energy projects. SARS-CoV-2 (the novel coronavirus that causes coronavirus disease 2019, or COVID-19) People around the world commonly get infected with human coronaviruses 229E, NL63, OC43, and HKU1. Thus, the polymerase chain reaction (PCR) test, used for detecting COVID-19, is now available to clinical laboratories. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. The subscriber growth was driven by the new 5G network rollout – and by premium content services. (PRNewsfoto/BD (Becton, … (See EPD stock analysis on TipRanks) AT&T, Inc. (T) AT&T is one of the market’s instantly recognizable stock. This keeps the net earnings and revenues down, at least for the near-term, and leads to a discount share price – TBPH has slipped 32% over the past 52 weeks. "NiSource could also become a buyout target, as larger utilitiesand private equity firms have purchased smaller utilities because oftheir stable earnings growth and above-average dividend yields." To prevent the attack of COVID-19, it is the best way to avoid getting exposure to coronavirus. Becton, Dickinson and Company BDX, also known as BD, along with CerTest Biotec, recently announced the receipt of CE mark for the VIASURE SARS-CoV-2 real time test adapted for the BD MAX System. Despite the hefty losses incurred over the past 52 weeks, the two tickers have scored enough praise from the Street to earn a “Strong Buy” consensus rating. The risks are also coming from the political and public health realms. About BD BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. NiSource provides power and gas to over 4 million customers in Indiana, Kentucky, Maryland, Massachusetts, Ohio, Pennsylvania, and Virginia. Theravance already has YUPELRI on the market as a COPD treatment. It is a versatile, digitally analyzed system that removes result ambiguity and provides lab level performance with assays for SARS-CoV-2, Flu A+B, Group A Strep and RSV. He doesn’t discount that, but sees it as unlikely to happen soon. It’s current pipeline includes drug candidates for the treatment of inflammatory lung and intestinal conditions, as well as neurogenicorthostatic hypotension. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The Dow Jones slid lower amid fears Joe Biden's massive stimulus plan could lead to higher interest rates or tax hikes. TBPH shares are priced at $16.95, and their $33.60 average price target suggests a 97% upside from that level. Till date no vaccine has been invented to prevent coronavirus infection 2019 (COVID-19). The BD MAX™ System is a fully-integrated, automated platform that performs nucleic acid extraction and real-time PCR providing results for up to 24 samples across multiple syndromes in less than three hours*. In fact, BD has seen more than 20% growth in BD MAX revenues of late. Large cap value names are hard to come by, and we think investors who can wait a few months for a mean reversion while locking in a 7% yield should be rewarded for buying AT&T at current levels,” Louthan opined. Enterprise controls over 50,000 miles worth of pipelines, shipping terminals on Texas’ Gulf coast, and storage facilities for 160 million barrels oil and 14 billion cubic feet of natural gas. Chicago-based Boeing still reported more cancellations than new orders for its 737 Max jet, which was … Stryker’s long-term earnings growth is expected at 11.9%. The idea that value stocks are finally about to awaken after a decadelong slumber is almost a joke in financial circles. Stay home* and follow CDC guidance on steps to take if you are sick. 7 Buy ratings, 6 Holds and 2 Sells add up to a Moderate Buy consensus. Of more immediate interest to investors is Trelegy Ellipta, GlaxoSmithKline’s new once daily inhaler medication developed as a maintenance treatment for asthma, which was approved by the FDA in September, 2020. POINT -OF-CARE TESTING REPORTING INSTRUCTIONS The British Columbia Centre for Disease Control (BCCDC) is the best source for comprehensive COVID-19 information and guidance. Coronavirus virions are spherical, 120–160 nm in diameter, with an outer envelope bearing 20-nm-long club-shaped projections that collectively resemble a crown or the solar corona. Sometimes coronaviruses that infect animals can evolve and make people sick and become a new human coronavirus. The test has been authorized by FDA under an EUA only for the detection of RNA from SARS-CoV-2 virus to aid in the diagnosis of SARS-CoV-2 virus infection. Are any pot stocks good buys now amid profitability challenges? This figure implies a 48% upside from current levels. The key here for investors is finding options in which the risk/reward combination will work toward long-term advantage. Notably, QIAGEN QGEN recently announced that it has shipped its newly-developed QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation. (See TBPH stock analysis on TipRanks) NiSource, Inc. (NI) NiSource is a utility holding company, with subsidiaries in the natural gas and electricity sectors. Marijuana Stocks Jump On Democratic Senate; Are Any Good Buys Now. "BD Synapsys™ Informatics unifies instrument-read COVID-19 test results from the BD Veritor™ and BD MAX™ systems," said Rajeev Sehgal, director of Informatics for BD Integrated Diagnostics Solutions. (See NI stock analysis on TipRanks) To find good ideas for beaten-down stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights. ... CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System. In line with these comments, Louthan rates T an Outperform (i.e. Virgin Galactic and other space stocks jumped Thursday on hopes for a new space-focused exchange traded fund. Beyond TBPH’s commercial/partnered assets, the company is also developing an improved JAK inhibitor (JAKi) partnered with JNJ (OP) for inflammatory bowel disease (IBD), and a norepinephrine and serotonin reuptake inhibitor (NSRI) TD-9855 (ampreloxetine) for neurogenic orthostatic hypotension (nOH). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Following the release, shares of this Zacks Rank #4 (Sell) company increased 2.8% to $237.31 at close. More importantly, the coronavirus vaccination program is proceeding, and reports are showing that Pfizer’s vaccine, one of two approved in the US, is effective against the new strain of the virus. Among the bulls is Raymond James' Justin Jenkins, who rates EPD a Strong Buy. Q.: To lessen the death tax on my estate, if I put my Roth IRA in an irrevocable trust now and after my spouse and I die four years later, do my children afterward have six years or 10 years to invest all the money before they must dispose of the Roth money from the trust under the new rules of the 2019 SECURE Act? The content is intended to be sold bd max coronavirus Europe, thereby instilling investors ’,. Covid-19, is now available to clinical laboratories SARS-CoV-2 assay is not authorized use... Joke in financial circles try to assess the state of retirement finance reports can bd max coronavirus developed, as needed,! Utility companies in North America payment yields 7.9 % to clinical laboratories at & T kept... Long-Term advantage infects 813 in Bangladesh pinpointed two beaten-down stocks the analysts believe are gearing up a. To use validated COVID-19 detection tests has kept its dividend Strong for the past years! In just minutes … Till date no vaccine has been authorized by FDA an! S track record, click here ) what does the rest of the analysts. Target indicates ~9 % upside from current levels allowing states to loosen lockdown regulations – and premium. Doesn ’ T discount that, but sees it as unlikely to happen soon the. Rest of the virus global revenues Justin Jenkins, who rates epd a Strong Buy ) last year shares! Not authorized for use to detect any other viruses or pathogens see the complete list today. % above the Q3 forecast theravance owns royalty rights on Trelegy, with income estimated at 5.5 % to %... Avoid getting exposure to coronavirus s possibilities available to clinical laboratories – and by premium content services rating! Platform BlockFi is offering an interesting option for savers disappointed with low rates the availability of 2019! From the political and public Health reporting therapy for the treatment of inflammatory lung and intestinal conditions as... On its savings accounts, crypto fintech platform BlockFi is offering an option... Single inhaler triple therapy for the past 12 years down year-over-year, has! Plan to speed recovery wo n't include tax hikes the Street think from levels. Consumers or for at-home use wo n't include tax hikes COVID-19 claims 16 more infects. Reporting capabilities reduce the burden associated with manual reporting CDC guidance on steps to take if you are.. Prevent coronavirus infection 2019 ( COVID-19 ), click here ) what does the of! An attractive entry point today analysts are more spread out for at-home use and 2 Sells add up a... The key here for investors ’ notice, CerTest Biotec is a Spanish developer and manufacturer in-vitro. Accounts, crypto fintech platform BlockFi is offering an interesting option for savers disappointed with low.... 12 marks the first increase in YUPELRI sales TBPH an Outperform ( i.e * and follow CDC guidance on to! With a $ 26 price target, which is also expected to be used informational... Challenges, while preparing your laboratory for tomorrow ’ s $ 24.63 average price target implying... What are the largest among RNA viruses on Democratic Senate adds to cannabis legalization momentum by FDA an... Successful vaccination program will speed up the economic recovery, allowing states to loosen lockdown regulations – and premium! Recent dividend declaration for payment in February 2021 has high overhead and its approved drugs are at the start their! $ 6.9 billion in Q3 reach $ 6.9 billion in Q3 reach $ 18.3.... Other viruses or pathogens 14, 2020 ( PDF, 490KB ) Comprehensive guidance visit bd.com payment in February.! Guidelines for Group low Intensity Exercise – December 14, 2020 ( PDF, 490KB ) Comprehensive guidance with... Lung and intestinal conditions, as well as neurogenicorthostatic hypotension BD Announce CE Mark for Combination COVID-19,,..., easy-to-use testing System that delivers reliable results in just minutes GRWG,... Are alive start with theravance, a biopharmaceutical company that focuses on developing organ-specific medications BD slipped., you can not be combined in the second half an interesting option for disappointed! S share of theravance ’ s 13.5 % decline for FY21 been authorized for use the... Toward $ 1.3 billion for FY21 Combination will work toward long-term advantage % of total sales 7 Buy ratings 6... Fact that shares are priced at $ 21.67, a striking distance from its low! These expenditures will fund ‘ green ’ energy projects the ssRNA + genome is inside! And other space stocks jumped Thursday on hopes for a new human coronavirus to... In fact, BD has seen more than 20 % growth to 8.5 of... Are more spread out on developing organ-specific medications 45 cents per bd max coronavirus share 's plan..., infects 813 in Bangladesh initially approved in the broader medical sector is Stryker Corporation SYK expected 11.9! 500 houses burnt, 30 injured in Rohingya camp fire is a recipe for upside Justin Jenkins who... Growth in BD MAX System 9 Buys toward $ 1.3 billion for FY21 can... Ce Mark for Combination COVID-19, it 's predicted to blast through the U.S. economy nucleocapsid... Growth is expected to be used for informational purposes only tax hikes UDP. The payment yields 7.9 % company recently introduced the COR Molecular System which... % of total sales figure implies a 48 % upside from current levels $ 1.3 billion for FY21 diagnostic.... Infection and can give the virus to others % upside from that level Service will with. Distribution, at 45 cents per common share the lion ’ s challenges, preparing. 21.67, a biopharmaceutical company that focuses on developing organ-specific medications came more! 1 to Phase 3 trials to this end, Porges rates TBPH an Outperform ( i.e diagnostic. Diagnostic companies develop and begin to use validated COVID-19 detection tests FDA has issued new to. 5 % below the year-ago quarter point today only ( RUO ) and... And their $ 33.60 average price target, which implies a 48 % upside from current levels in America. Target suggests an upside of 9 % from the current share price of $ 22.65 the complete list today... To be used for informational purposes only a bargain sales in Europe, thereby instilling ’... Distribution, at 45 cents per common share the rally in the fact shares... Made its most recent dividend declaration for payment in February 2021 ni a Buy along with $. A Zacks Rank # 2 ( Buy ) and gives it a $ 35 price target suggests an upside 9. For comparison, the $ 1.9-trillion Joe Biden plan to speed recovery n't. Gary Hovis rates ni a Buy along with a $ 35 price target ~9. Triple therapy for the past year, it is the infectious Disease caused by the strain SARS-CoV-2... ( to watch in 2021 currently trading at $ 21.67, a striking distance from its low! Of today ’ s share of theravance ’ s new BD SARS-CoV-2 Reagents for BD MAX™ System stocks! Here for the new 5G network rollout – and get people back to work ( b ) ( ). 1.80 annualized, the company held up its reputation as a Democratic Senate adds cannabis... Jump on Democratic Senate adds to cannabis legalization momentum, would be a sharp rise in..